Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19
Clinical trial NCT04918927 · COMPLETED
Trial details
- NCT number
- NCT04918927
- Sponsor
- Coordinación de Investigación en Salud, Mexico
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2023-03-21
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.